NCT07419893

Germline Genetic Testing of the TP53 Gene

Germline Genetic Testing of the TP53 Gene: Identification, Characterization, and Management of Patients and Families at High Risk of Cancer

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 1,940 (estimated)
• Sponsor: European Institute of Oncology · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

This is a retrospective, observational, single-center study designed as a cohort analysis. The study population will include consecutive patients referred for genetic counseling and TP53 germline genetic testing between 2004 and 2025 at the Division of Cancer Prevention and Genetics of the IEO. The primary endpoint is to determine the overall detection rate of Pathological Variants (PVs) in the TP53 gene among individuals referred to the institute and the differences between the groups.

Conditions

• TP53 Gene Mutation
• Multi-Gene Transcriptional Profiling
• TP53 Gene Germline Mutation Carrier

Timeline

• Start date: 2026-01-29
• Primary completion: 2026-07-01
• Completion: 2031-01-01
• First posted: 2026-02-19
• Last updated: 2026-02-19

Locations

1 site across 1 country: Italy